AMITRIC 250
Powerful Protection Against Severe Infections
AMITRIC-250 Injection is a powerful aminoglycoside antibiotic formulated with Amikacin Sulphate 250mg/2ml, designed to treat a wide range of serious bacterial infections. It works by inhibiting bacterial protein synthesis, ultimately stopping bacterial growth and killing infection-causing organisms.
Manufactured with high-quality standards by Citric Labs, this injection is widely trusted in hospitals and clinical settings for its fast-acting and effective antibacterial action.
Composition
- Amikacin Sulphate IP – 250mg/2ml
Key Benefits
- Broad-spectrum antibiotic coverage
- Fast and effective action against severe infections
- Suitable for hospital and clinical use
- Reliable treatment for resistant bacterial strains
- High-quality formulation by Citric Labs
Product Description
AMITRIC-250 Injection contains Amikacin Sulphate 250mg/2ml, a potent aminoglycoside antibiotic used for the treatment of severe bacterial infections such as respiratory, urinary tract, and blood infections. It provides fast and effective action against a wide range of Gram-negative bacteria and is administered under medical supervision.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
